178 related articles for article (PubMed ID: 18843767)
1. Differential response of psoriatic onycho-pachydermo-periostitis to 2 anti-tumor necrosis factor-alpha agents.
Kapusta MA; Dumont C
J Rheumatol; 2008 Oct; 35(10):2077-80. PubMed ID: 18843767
[No Abstract] [Full Text] [Related]
2. Successful treatment of psoriatic onycho-pachydermo periostitis (POPP) with adalimumab.
Bongartz T; Härle P; Friedrich S; Karrer S; Vogt T; Seitz A; Müller-Ladner U
Arthritis Rheum; 2005 Jan; 52(1):280-2. PubMed ID: 15641098
[TBL] [Abstract][Full Text] [Related]
3. Psoriatic onycho-pachydermo periostitis.
Srivastava M; Solomon G; Strober B
Dermatol Online J; 2007 Jan; 13(1):20. PubMed ID: 17511953
[TBL] [Abstract][Full Text] [Related]
4. Carnitine: a therapeutic option for childhood psoriatic onycho-pachydermo-periostitis (POPP).
Fietta P; Manganelli P
Clin Rheumatol; 2007 Jan; 26(1):93-4. PubMed ID: 16738841
[TBL] [Abstract][Full Text] [Related]
5. [Psoriatic onycho-pachydermo- periostitis].
Kroiss MM; Vogt T; Finkenzeller T; Landthaler M; Stolz W
Z Rheumatol; 2002 Oct; 61(5):598-600. PubMed ID: 12399889
[TBL] [Abstract][Full Text] [Related]
6. Psoriatic onycho-pachydermo-periostitis successfully treated with low-dose methotrexate.
Ochiai T; Washio H; Shiraiwa H; Takei M; Sawada S
Med Sci Monit; 2006 Apr; 12(4):CS27-30. PubMed ID: 16572055
[TBL] [Abstract][Full Text] [Related]
7. [Psoriatic onycho-pachydermo- periostitis].
Anders HJ; Sanden S; Krüger K
Z Rheumatol; 2002 Oct; 61(5):601-4. PubMed ID: 12399890
[TBL] [Abstract][Full Text] [Related]
8. [Psoriatic onycho-pachydermo-periostitis].
De Pontville M; Dompmartin A; De Raucourt S; Macro M; Rémond B; Leroy D
Ann Dermatol Venereol; 1993; 120(3):229-32. PubMed ID: 8239363
[TBL] [Abstract][Full Text] [Related]
9. [Psoriatic onycho-pachydermo-periostitis].
Miehle W
Z Rheumatol; 2002 Oct; 61(5):597. PubMed ID: 12399888
[No Abstract] [Full Text] [Related]
10. Psoriatic onychopachydermoperiostitis: improvement with etanercept.
Dans M; Hivnor C; van Voorhees AS
Br J Dermatol; 2005 Oct; 153(4):858-9. PubMed ID: 16181482
[No Abstract] [Full Text] [Related]
11. Successful rechallenge with anti-tumor necrosis factor alpha for psoriatic arthritis after development of demyelinating nervous system disease during initial treatment: comment on the article by Mohan et al.
Cisternas M; Gutiérrez M; Jacobelli S
Arthritis Rheum; 2002 Nov; 46(11):3107-8; author reply 3108-9. PubMed ID: 12428265
[No Abstract] [Full Text] [Related]
12. Clinical images: Drumstick-like fingers indicating psoriatic onycho-pachydermo periostitis.
Tsubota A; Abe R; Shibaki A
Arthritis Rheum; 2005 Sep; 52(9):2954. PubMed ID: 16142729
[No Abstract] [Full Text] [Related]
13. Childhood onset of psoriatic onycho-pachydermo-periostitis (POPP).
Fietta P; Manganelli P
J Eur Acad Dermatol Venereol; 2005 Nov; 19(6):780-2. PubMed ID: 16268902
[No Abstract] [Full Text] [Related]
14. Childhood-onset psoriatic onycho-pachydermo-periostitis treated successfully with infliximab.
Watabe D; Endoh K; Maeda F; Akasaka T; Endoh M
Eur J Dermatol; 2015; 25(5):506-8. PubMed ID: 26243308
[No Abstract] [Full Text] [Related]
15. Development of bullous pemphigoid during treatment of psoriatic onycho-pachydermo periostitis with ustekinumab.
Nakayama C; Fujita Y; Watanabe M; Shimizu H
J Dermatol; 2015 Oct; 42(10):996-8. PubMed ID: 26010891
[TBL] [Abstract][Full Text] [Related]
16. Healing of psoriatic skin lesions, and improvement of psoriatic arthritis resistant to immunosuppressive drugs, after infliximab treatment.
Nikas SN; Voulgari PV; Takalou IP; Katsimbri P; Drosos AA
Ann Rheum Dis; 2005 Nov; 64(11):1665-7. PubMed ID: 16227426
[No Abstract] [Full Text] [Related]
17. Psoriatic onycho-pachydermo periostitis (POPP): a case report treated successfully with IL-17 blockade and a literature review on characteristics, pathogenesis, and treatment.
Sakellariou GT; Tsifountoudis I; Vounotrypidis P
Clin Rheumatol; 2021 Nov; 40(11):4749-4757. PubMed ID: 33830360
[TBL] [Abstract][Full Text] [Related]
18. Infliximab in refractory psoriatic arthritis with severe psoriasis: a 2-year experience.
Voulgari PV; Venetsanopoulou AI; Epagelis EK; Alamanos Y; Takalou I; Drosos AA
Ann Rheum Dis; 2007 Feb; 66(2):270-1. PubMed ID: 17068063
[No Abstract] [Full Text] [Related]
19. Kaposi's sarcoma in a psoriatic arthritis patient treated with infliximab.
Ursini F; Naty S; Mazzei V; Spagnolo F; Grembiale RD
Int Immunopharmacol; 2010 Jul; 10(7):827-8. PubMed ID: 20433950
[No Abstract] [Full Text] [Related]
20. Arthralgia as an adverse event to infliximab: a reactive arthritis or triggering of psoriatic arthritis? Successful management by switching to etanercept.
Moustou AE; Stratigos AJ; Vergou T; Gregoriou S; Georgala S; Danopoulou I
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):968-9. PubMed ID: 19207660
[No Abstract] [Full Text] [Related]
[Next] [New Search]
